RESUMEN
Ionizing radiation is known as a classical mutagen capable of inducing various kinds of stable and unstable chromosomal aberrations. The percentage of cells with chromosomal aberrations was analyzed in peripheral blood lymphocytes of occupationally exposed workers in radiotherapy, CT-scan, angiography and healthy controls. The incidence of all types of aberrations (gap, acentric fragment, dicentric and ring) in exposed subjects were higher than those observed in healthy controls (P=0.0001). However, the frequency of aberrant cells with dicentric and ring chromosome in exposed subjects were not significantly different from those in controls. To see whether there is a significant difference in the incidence of chromosomal aberrations among three groups, they were compared for all types of observed aberrations. No significant difference was found between radiotherapy and CT-scan groups (P=0.838). The percentage of aberrant cells observed, for angiography groups were significantly higher than radiotherapy (P=0.0001) and CT-scan (P=0.0001) group. Taken together these data suggest that the cumulative effects of low level chronic exposure to ionizing radiation is higher for those who occupationally exposed in angiography.
Asunto(s)
Angiocardiografía/efectos adversos , Aberraciones Cromosómicas , Exposición Profesional , Personal de Hospital , Radiación Ionizante , Radioterapia/efectos adversos , Tomografía Computarizada por Rayos X/efectos adversos , Adulto , Femenino , Humanos , Linfocitos/efectos de la radiación , Masculino , Dosis de Radiación , Servicio de Radiología en Hospital , Adulto JovenRESUMEN
We performed an experimental study of the influence on pacemakers (PM) of X-rays from the angiocardiography equipment. (1) We used one PM of DDD mode in this study. (2) The PM was irradiated under two exposure levels: one the standard dose and the other the maximum dose in the angiocardiography study situation. (3) We set the pacing lead wires to the bilateral atria and ventricles in Irnich's human body model. (4) We set two irradiation fields, one with a lead block on the PM and the other without the lead block. The result showed that when the PM was included in the irradiation field and the exposure level was of the maximum dose, the influence of irradiation on the PM was that of level 2 as classified by a research report by the Ministry of Internal Affairs and Communications. The absorbed dose of the PM was 93.4 mGy under these conditions. We confirmed that radiation dose does not affect a pacemaker with pacing lead wire. However, it acts on the generator of the PM owing to the direct photoelectric effect. When there were many dose rates (or total radiation dose), an obstacle occurred.
Asunto(s)
Angiocardiografía/efectos adversos , Marcapaso Artificial , Angiocardiografía/instrumentación , Humanos , Modelos Biológicos , Dosis de RadiaciónRESUMEN
PURPOSE: To compare the effects on heart rate (HR), on left ventricular (LV) or arterial pressures, and the general safety of a non-ionic low-osmolar contrast medium (CM) and a non-ionic iso-osmolar CM in patients undergoing cardiac angiography (CA) or peripheral intra-arterial digital subtraction angiography (IA-DSA). MATERIALS AND METHODS: Two double-blind, randomized studies were conducted in 216 patients who underwent CA (n=120) or peripheral IA-DSA (n=96). Patients referred for CA received a low-osmolar monomeric CM (iomeprol-350, n=60) or an iso-osmolar dimeric CM (iodixanol-320; n=60). HR and LV peak systolic and end-diastolic pressures were determined before and after the first injection during left and right coronary arteriography and left ventriculography. Monitoring for all types of adverse event (AE) was performed for 24 h following the procedure. t-tests were performed to compare CM for effects on HR. Patients referred for IA-DSA received iomeprol-300 (n=49) or iodixanol-320 (n=47). HR and arterial blood pressure (BP) were evaluated before and after the first 4 injections. Monitoring for AE was performed for 4 h following the procedure. Repeated-measures ANOVA was used to compare mean HR changes across the first 4 injections, whereas changes after the first injection were compared using t-tests. RESULTS: No significant differences were noted between iomeprol and iodixanol in terms of mean changes in HR during left coronary arteriography (p=0.8), right coronary arteriography (p=0.9), and left ventriculography (p=0.8). In patients undergoing IA-DSA, no differences between CM were noted for effects on mean HR after the first injection (p=0.6) or across the first 4 injections (p=0.2). No significant differences (p>0.05) were noted in terms of effects on arterial BP in either study or on LV pressures in patients undergoing CA. Non-serious AE considered possibly CM-related (primarily headache and events affecting the cardiovascular and digestive systems) were reported more frequently by patients undergoing CA and more frequently after iodixanol (14/60 [23.3%] and 2/47 [4.3%]; CA and IA-DSA, respectively) than iomeprol (10/60 [16.7%] and 1/49 [2%], respectively). CONCLUSIONS: Iomeprol and iodixanol are safe and have equally negligible effects on HR and LV pressures or arterial BP during and after selective intra-cardiac injection and peripheral IA-DSA. CLINICAL APPLICATION: Iomeprol and iodixanol are safe and equally well tolerated with regard to cardiac rhythm and clinical preference should be based on diagnostic image quality alone.
Asunto(s)
Angiografía de Substracción Digital/métodos , Enfermedad Coronaria/diagnóstico por imagen , Yopamidol/análogos & derivados , Ácidos Triyodobenzoicos/administración & dosificación , Adulto , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Angiocardiografía/efectos adversos , Angiocardiografía/métodos , Presión Sanguínea/efectos de los fármacos , Determinación de la Presión Sanguínea , Medios de Contraste/administración & dosificación , Medios de Contraste/efectos adversos , Enfermedad Coronaria/fisiopatología , Método Doble Ciego , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Inyecciones Intraarteriales , Inyecciones Intralesiones , Yopamidol/administración & dosificación , Yopamidol/efectos adversos , Masculino , Persona de Mediana Edad , Probabilidad , Medición de Riesgo , Ácidos Triyodobenzoicos/efectos adversosAsunto(s)
Angiocardiografía , Cateterismo Cardíaco , Isquemia Miocárdica/diagnóstico , Adulto , Angiocardiografía/efectos adversos , Angiocardiografía/métodos , Aortografía , Cateterismo Cardíaco/efectos adversos , Cateterismo Cardíaco/métodos , Medios de Contraste , Angiografía Coronaria , Ventrículos Cardíacos/diagnóstico por imagen , HumanosRESUMEN
Se revisan 951 cateterismos realizados de 1980 a febrero de de 1994, en el Laboratorio de Hemodinámica del Hospital Obrero de La Paz, con el interés de determinar el porcentaje de cateterismos pediátricos (menores de 17 años), en relación al total, determinar la patología encontrada, revisar la metodología y verificar la confiabilidad del procedimiento en relación a las posibles complicaciones. Retrospectivamente, encontramos 374 catetetrismos realizados en menoresde 17 años (media de 7 años).
Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Lactante , Preescolar , Pediatría , Angiocardiografía/efectos adversos , Cateterismo , Bolivia , Ecocardiografía , Efecto Doppler , Hemodinámica/fisiologíaRESUMEN
OBJECTIVE: To examine the effects of ambulation at 3 versus 6 hours on delayed bleeding, pain, and anxiety in patients after cardiac angiogram. DESIGN: Experimental, pretest posttest, random assignment. SETTING: Western Canadian University-affiliated tertiary care hospital. PATIENTS: Thirty-nine patients who underwent cardiac angiograms. OUTCOME MEASURES: Delayed bleeding, pain, and anxiety. INTERVENTION: The experimental group ambulated at 3 hours after cardiac angiogram; the control group ambulated at 6 hours. Delayed bleeding was evaluated by sanguinous drainage through a standard gauze pressure dressing and/or the presence of a palpable hematoma greater than 5 cm in width. Melzack's Present Pain Intensity Scale and Spielberger's State Anxiety Inventory were used to evaluate patient comfort at 2, 4, and 7 hours after angiogram and the next day. RESULTS: None of the patients experienced any delayed bleeding. Student's t test was used to compare pain levels and anxiety scores. In addition, repeated measures analysis of variance was applied to pain scores taken at 4 hours, 7 hours, and the next day. The 2-hour observation data were used as a covariate and a basis for comparison of pain at the next three observations. Patients ambulating early had significantly less pain overall (p < 0.005) and less back pain at 4 and 7 hours after angiogram (p < 0.05). There was no significant difference in the mean anxiety scores. CONCLUSION: The significant decrease in back pain of patients who ambulated earlier demonstrates the need to consider patient comfort as well as the potential risks and sequelae of delayed bleeding.
Asunto(s)
Angiocardiografía/efectos adversos , Ansiedad/etiología , Ambulación Precoz , Hemorragia/etiología , Dolor/etiología , Adulto , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Ansiedad/prevención & control , Dolor de Espalda/etiología , Dolor de Espalda/prevención & control , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dolor/prevención & control , Proyectos Piloto , Distribución AleatoriaRESUMEN
Cardiac tamponade secondary to ventricular wall perforation is one of the possible complications of right-sided as well as left-sided cardiac catheterization. Ventriculography was performed on a patient with obstructive cardiomyopathy using a nonionic contrast medium. During the procedure, the right ventricle was accidentally perforated and the patient developed cardiac tamponade. Pericardiocentesis was unsuccessful and surgical drainage was needed after the patient developed progressive hemodynamic deterioration. At surgery, pericardial thrombus was found. We consider the reason for failure of pericardiocentesis was rapid coagulation of the extravasated blood in connection with nonionic contrast material.
Asunto(s)
Angiocardiografía/efectos adversos , Cateterismo Cardíaco/efectos adversos , Taponamiento Cardíaco/etiología , Taponamiento Cardíaco/terapia , Lesiones Cardíacas/etiología , Yohexol/efectos adversos , Trombosis/inducido químicamente , Anciano , Drenaje/métodos , Femenino , Lesiones Cardíacas/complicaciones , Ventrículos Cardíacos/lesiones , Humanos , Punciones , Insuficiencia del TratamientoRESUMEN
Risk factors for contrast nephropathy were prospectively studied in 17 patients with non-insulin dependent diabetes mellitus undergoing cardioangiography. Contrast nephropathy, defined as a serum creatinine increase of greater than 25% at 3 day after angiography, occurred in 29.4% of diabetic patients. Patients who developed contrast nephropathy had significantly higher serum creatinine (Cr), fractional excretion of sodium (FENa), urinary albumin excretion rate (AER), and lower 24hr Ccr than patients who did not (Cr: 1.5 +/- 0.3 mg/dl vs. 0.8 +/- 0.1 mg/dl, FENa: 1.9 +/- 0.5% vs. 0.6 +/- 0.1%, AER: 522 +/- 335 micrograms/min vs. 27 +/- 13 micrograms/min, 24hr Ccr: 39.1 +/- 11.6 ml/min vs. 86.2 +/- 9.3 ml/min, P < 0.05). Contrast nephropathy developed in all of two patients with overt proteinuria (AER more than 200 micrograms/min), but none of eight patients with normoalbuminuria (AER below 15 micrograms/min). Three of seven patients with microalbuminuria developed contrast nephropathy, and two of them had advanced nephropathy. FENa obtained next day was significantly elevated over baseline in patients with contrast nephropathy (1.9 +/- 0.5% vs. 9.7 +/- 4.5%, P < 0.05), but unchanged in patients without contrast nephropathy. The rise in C beta 2-microglobulin/Ccr and enzymuria was noted in both group. Percentage decrease of Ccr on the next day was positively correlated with FENa before angiography (r = 0.645, p < 0.01). Of 24hr Ccr, AER, and FENa before angiography, FENa was revealed as a statistically significant discriminant factor for contrast nephropathy by stepwise discriminant analysis (p = 0.0008). These results suggest that contrast nephropathy develops predominantly in the stage not of incipient but of overt diabetic nephropathy indicated by a decline of glomerular filtration, overt proteinuria, and tubular dysfunction. Of them, tubular dysfunction may be the most important risk factor for contrast nephropathy.
Asunto(s)
Angiocardiografía/efectos adversos , Medios de Contraste/efectos adversos , Diabetes Mellitus Tipo 2/diagnóstico por imagen , Nefropatías Diabéticas/inducido químicamente , Riñón/fisiopatología , Anciano , Albuminuria , Creatinina/sangre , Nefropatías Diabéticas/fisiopatología , Femenino , Tasa de Filtración Glomerular , Humanos , Riñón/efectos de los fármacos , Pruebas de Función Renal , Túbulos Renales/fisiopatología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de RiesgoRESUMEN
This article described a 19-year-old woman with homozygous sickle disease in whom multiple cerebral infarcts developed after a technically uncomplicated cardiac angiogram. The article highlighted the risks of hyperosmolar solutions in patients with sickle cell disease and emphasized that only low osmolar contrast media, nonionic or ionic, should be used.
Asunto(s)
Angiocardiografía/efectos adversos , Ceguera/etiología , Adulto , Anemia de Células Falciformes/complicaciones , Anemia de Células Falciformes/diagnóstico por imagen , Ceguera/diagnóstico , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Infarto Cerebral/diagnóstico , Infarto Cerebral/etiología , Diatrizoato de Meglumina/efectos adversos , Femenino , Humanos , Imagen por Resonancia Magnética , Tomografía Computarizada por Rayos XRESUMEN
To evaluate the occurrence of complications during diagnostic or interventional catheterization a retrospective analysis of catheterization procedures in 12 Italian laboratories using the nonionic contrast medium (CM) iopamidol (370 mgI/ml) was performed. Data obtained on 26,219 patients greater than or equal to 14 years are presented. The overall complication rate was 1.89% (485/26,219). The overall mortality rate was 0.1% (27/26,219). Procedure related complications were 389 (1.48%) and CM related complications were 106 (0.4%). No death was attributed to CM. Ventricular fibrillation (VF) rate was 0.11% comparable to the low rate observed with nonionic CM in other studies and less than the rate observed in surveys concerning the use of ionic CM. Fifty-seven thrombotic events were recorded (0.22%), a rate comparable with other surveys with ionic and nonionic CM. The total complication rate (6.1%), the rates of coronary occlusion (1.34%), myocardial infarction (0.37%) and urgent coronary artery by-pass grafting (0.5%) in 1,348 coronary angioplasties were lower than those recorded in previous surveys. These data confirm a good tolerability and no increased risk of VF and thrombotic events with iopamidol in cardiac catheterization.
Asunto(s)
Angiocardiografía/métodos , Yopamidol , Adulto , Factores de Edad , Angiocardiografía/efectos adversos , Angiocardiografía/mortalidad , Angiocardiografía/estadística & datos numéricos , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/mortalidad , Evaluación de Medicamentos , Humanos , Yopamidol/administración & dosificación , Yopamidol/efectos adversos , Italia/epidemiología , Estudios Retrospectivos , Factores SexualesRESUMEN
To evaluate the complication rate in paediatric cardioangiography with the nonionic contrast medium iopamidol data on 8,166 procedures were retrospectively collected in 12 centres. The overall complication rate was 3.78% (309/8,166). 3.44% were related to the procedure, and 0.34% to the contrast medium. The mortality rate varied with age. It was higher in patients less than 2 months (0.38%) than in patients greater than 2 months-2 years (0.06%) and in patients older than 2 years (0.03%). The total complication rate was higher than the one observed in a similar retrospective analysis performed in adult patients (1.89%). This difference is probably due to higher risk conditions of the younger patients. However the contrast medium related complication rate (0.34% vs 0.4%) and the mortality rate (0.11% vs 0.1%) were comparable, confirming the good tolerability of iopamidol in cardiac catheterisation also in paediatric patients.
Asunto(s)
Angiocardiografía/métodos , Yopamidol , Factores de Edad , Angiocardiografía/efectos adversos , Angiocardiografía/mortalidad , Angiocardiografía/estadística & datos numéricos , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/mortalidad , Niño , Evaluación de Medicamentos , Humanos , Yopamidol/administración & dosificación , Yopamidol/efectos adversos , Italia/epidemiología , Estudios Retrospectivos , Factores SexualesAsunto(s)
Angiografía/instrumentación , Cateterismo Periférico/instrumentación , Yohexol/efectos adversos , Yopamidol/efectos adversos , Ácido Yoxáglico/efectos adversos , Angiocardiografía/efectos adversos , Angiocardiografía/instrumentación , Angiografía/efectos adversos , Sangre/efectos de los fármacos , Cateterismo Periférico/efectos adversos , Interacciones Farmacológicas , Humanos , Microscopía Electrónica de Rastreo , Propiedades de Superficie , Trombosis/etiologíaRESUMEN
The effects of adding NaCl to the non-ionic contrast medium iohexol (Omnipaque) were investigated in the isolated rat heart. Iohexol (150 mgI/ml) with 0, 10, 20, 30, 50, 145 mM NaCl added and the ionic dimeric compound ioxaglate (Hexabrix 160 mgI/ml) containing approximately 75 mM NaCl were examined. Coronary flow rate (CFR), heart rate (HR), left ventricular developed pressure (LVDP) and myocardial high energy phosphate compounds at the end of the experiments were measured. In all groups examined the physiological changes following contrast media injection were only transient and the recovery to normal values of HR and LVDP occurred within 30 seconds. The contractile changes after contrast media exposure were dependent on the concentration of sodium added. The addition of 20 mM sodium to iohexol induced the least changes in LVDP. It is concluded from the present study that addition of sodium in the range of 20-40 mM to non-ionic contrast media, may reduce the immediate cardiac disturbances during coronary angiography.
Asunto(s)
Angiocardiografía/efectos adversos , Medios de Contraste/efectos adversos , Contracción Miocárdica/efectos de los fármacos , Sodio/química , Animales , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Frecuencia Cardíaca/efectos de los fármacos , Yohexol , Ácido Yoxáglico , Masculino , Miocardio/metabolismo , Concentración Osmolar , Fosfatos/metabolismo , Ratas , Ratas Endogámicas , Función Ventricular Izquierda/efectos de los fármacosRESUMEN
To characterize the frequency of adverse reactions to conventional ionic contrast agents, data describing the frequency of such reactions were gathered from 4,630 diagnostic cardiac angiographic procedures. The patient population had a large prevalence of severe or unstable cardiac disease (56% had New York Heart Association class III, IV or V, 12.6% had left ventricular end-diastolic pressure greater than 25 mm Hg and 34% had 3-vessel or left main coronary artery disease). The overall minor adverse reaction rate was 14.2%. Major adverse reactions (requiring treatment) occurred in 61 (1.3%) of procedures. All adverse reactions were managed successfully and there were no deaths. Adverse reactions were more frequent in patients with higher New York Heart Association classes and with elevated left ventricular end-diastolic pressure. The adverse reaction rate was not increased in patients with more extensive coronary artery disease, reduced left ventricular ejection fraction or reduced cardiac index. The overall adverse reaction rate was probably influenced by physician behavior. Smaller volumes of contrast agent were administered to patients with more severe cardiac disease. Six percent of procedures were abbreviated either because of an adverse reaction or of concern that a reaction might occur if the procedure were continued. As a result, the diagnostic data obtained were judged to be inadequate in 0.8% of procedures. These data demonstrate that appropriate operator caution within the highly monitored environment of the cardiac catheterization laboratory allows cardiac angiography to be performed safely with conventional ionic contrast agents in most patients.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Angiocardiografía/efectos adversos , Medios de Contraste/efectos adversos , Anciano , Enfermedad Coronaria/diagnóstico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Concentración Osmolar , Proyectos de InvestigaciónRESUMEN
Parental permission for cardiac catheterization assumes detailed information about the character and frequency of all potential and inevitable threatening complications despite of maximal care. However, data on this subject were derived mainly from older and/or retrospective studies. In order to evaluate the actual risk we performed a prospective study lasting 11 months. All complications occurring during the 24 h following this invasive procedure were recorded. During 462 consecutive cardiac catheterizations in 421 patients (including 24 balloon-atrio-septostomies and five myocardial biopsies) there were complications requiring treatment in 18.2% of all examinations. There was no lethal complication. The following complications were documented: arrhythmia 6.5%, acidosis 6.1%, problems due to catheterizing an arterial or venous vessel 3.9% and 0.4% respectively; acute blood loss 1.5%, and problems concerning the probe in general 1.1%. In a frequency of less than 1% we encountered hypoxic spells, myocardial ischemia, hypoventilation/respiratory failure, febrile reaction, and allergic reactions due to contrast media. Contrary to data of the literature we could show a significant reduction of the risks involved in this examination. The following factors have contributed to this improvement: 1) a more careful patient selection for this invasive procedure; 2) a more experienced examiner; 3) better monitoring during the procedure; 4) a more detailed diagnostic work-up prior to the examination; and 5) better premedication of the patient.
Asunto(s)
Angiocardiografía/efectos adversos , Cateterismo Cardíaco/efectos adversos , Cardiopatías Congénitas/diagnóstico , Acidosis/etiología , Arritmias Cardíacas/etiología , Cateterismo/efectos adversos , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Estudios Prospectivos , Factores de Riesgo , Tromboflebitis/etiologíaAsunto(s)
Angiocardiografía/efectos adversos , Colesterol , Embolia/etiología , Anciano , Humanos , MasculinoRESUMEN
Unexpected occurrence of coronary artery spasm is sometimes observed during cardiac catheterization. We report here two cases of coronary artery spasm with hypotension and urticaria subsequent to administration of contrast material. The etiology of coronary artery spasm is discussed.
Asunto(s)
Angiocardiografía/efectos adversos , Medios de Contraste/efectos adversos , Vasoespasmo Coronario/etiología , Cateterismo Cardíaco , Enfermedad de la Arteria Coronaria/complicaciones , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
A retrospective review of patients with coronary angiography was undertaken to establish the incidence of ventricular fibrillation and other serious arrhythmias and to identify possible causative factors, in particular whether the use of non-ionic contrast medium increased the risk of a serious arrhythmia. Out of 3660 patients reviewed there were 10 cases of ventricular fibrillation. In all cases, there were identifiable technical factors thought to have accounted for the arrhythmia. There were no cases of ventricular fibrillation complicating a technically satisfactory injection of ionic or non-ionic contrast medium. There was no significant difference in the incidence of serious arrhythmias between patients given ionic and those given non-ionic contrast medium.
Asunto(s)
Angiocardiografía/efectos adversos , Medios de Contraste/efectos adversos , Fibrilación Ventricular/etiología , Cateterismo Cardíaco , Estudios de Cohortes , Diatrizoato , Humanos , Yopamidol , Estudios Retrospectivos , Fibrilación Ventricular/diagnósticoRESUMEN
We report a case of acute myocardial infarction following a hyperventilation test performed at coronary angiography. The potential pathophysiological mechanisms and clinical implications are discussed.